News Focus
News Focus
icon url

$Pistol Pete$

03/21/17 1:32 AM

#13992 RE: $Pistol Pete$ #13991

$SPOM A Major Revenue Partnership SPOM

Feb 21, 2017
OTC Disclosure & News Service

Woburn, MA -

A Major Revenue Partnership
To All Shareholders: Woburn / 21 Feb, 2017.
SPO Global subsidiary Reflective Solutions are pleased to announce a very important revenue partnership with India first value added solutions Distribution Company: InventiusTech.

Inventius and Reflective Solutions have already engaged with a number of major clients in the banking sector and look to close some of these deals in the coming quarter. 2017 will see our sales in this region ramp up significantly due to this new partnership.
InventiusTech is focused towards aligning with technology vendors who provide niche products and promoting best of breed solutions via their network of some 200 channel partners in India and see Reflective Solutions and its suite of products a perfect fit.
For more information please see: http://inventiustech.com/

Our joint sales and marketing efforts over the coming months will focus on the banking sector in India and in particular their Core Banking Systems (CBS). In this age of ever increasing use of mobile banking applications and demonetization within the banking industry in India, there are potentially 1000s of new end users enrolling every week on mobile banking apps, and millions of additional banking transactions per week.........StressTester from Reflective Solutions will ensure Core Banking Systems (CBS) can meet the needs of these customers without any degradation to the online banking service, and gives confidence to the banks to have their systems ready for these increased transaction rates. Our solutions will address the following:
• Ensure the CBS can handle large amounts of activity or load.
• Ensure Apps and website run efficiently.
• Avoid customers access being denied.
• Reduce downtime.
• Increase customer satisfaction.


We are very pleased you can be a part of our future success
Owen Dukes







This shareholder letter contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, expectations regarding the successful expansion of our product base, profitability, market acceptance of our products and new product applications, timing of new product launches, product performance, size of prospective markets, marketing strategies, success of our restructured operations and plans, our ability to generate fees or raise


capital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans, patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us. We undertake no obligation to revise or update any forward-looking statement for any reason.




Copyright © 2017 OTC Markets. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.